Alexander Vogetseder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alexander Vogetseder has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Ospelt
Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
1 shared publication - Erich Schmutzhard
Department of Neurology, University Hospital, Innsbruck, Austria
1 shared publication - Maria Schober
University Hospital Innsbruck, Department of Neurology and Central Laboratories, Innsbruck, Austria
1 shared publication - Markus Reindl
Clinical Department of Neurology, Medical University of Innsbruck
1 shared publication
Latest Publications
- Open Access
- 1 July 2004
- Published by Wiley in Tropical Medicine & International Health
- Vol. 9 (7) , 767-773
Time course of coagulation parameters, cytokines and adhesion molecules in Plasmodium falciparum malaria
Summary: We studied 38 patients with malaria tropica over a period of 5 days during antiparasitic therapy. Serum or plasma levels of interleukin (IL) 1β, IL‐6, IL‐10, tumour necrosis factor‐α (TNF‐α), the soluble vascular adhesion molecule (sVCAM) and the soluble intracellular adhesion molecule (sICAM) were determined by enzyme‐linked immunosorbent assay. Protein C and antithrombin III activity were analysed by chromogenic tests and protein S activity by a clotting test. Antithrombin III, protein C and protein S activity was significantly lower in patients with severe malaria and displayed a highly significant increase in activity over the time of evaluation. Levels of sVCAM and sICAM were increased for the whole study period, but no significant differences were found between severe and mild malaria cases. Serum IL‐1β, IL‐6 and IL‐10 levels were significantly higher in patients with severe malaria, whereas no significant differences were found for TNF‐α. IL‐6 and IL‐10 decreased significantly over 5 days during schizontocidal therapy. Our data show an impairment of the coagulation system which correlates with pro‐inflammatory cytokines and therefore with the severity of the disease.
- 1 July 2004
- Published by Wiley in Tropical Medicine & International Health
- Vol. 9 (7) , 767-773
Open AccessTime course of coagulation parameters, cytokines and adhesion molecules in Plasmodium falciparum malaria
Summary: We studied 38 patients with malaria tropica over a period of 5 days during antiparasitic therapy. Serum or plasma levels of interleukin (IL) 1β, IL‐6, IL‐10, tumour necrosis factor‐α (TNF‐α), the soluble vascular adhesion molecule (sVCAM) and the soluble intracellular adhesion molecule (sICAM) were determined by enzyme‐linked immunosorbent assay. Protein C and antithrombin III activity were analysed by chromogenic tests and protein S activity by a clotting test. Antithrombin III, protein C and protein S activity was significantly lower in patients with severe malaria and displayed a highly significant increase in activity over the time of evaluation. Levels of sVCAM and sICAM were increased for the whole study period, but no significant differences were found between severe and mild malaria cases. Serum IL‐1β, IL‐6 and IL‐10 levels were significantly higher in patients with severe malaria, whereas no significant differences were found for TNF‐α. IL‐6 and IL‐10 decreased significantly over 5 days during schizontocidal therapy. Our data show an impairment of the coagulation system which correlates with pro‐inflammatory cytokines and therefore with the severity of the disease.